Download PDF
J Reconstr Microsurg 2023; 39(06): 444-452
DOI: 10.1055/a-1947-8212
Original Article

The Association between Breast Cancer Related Lymphedema and Area Deprivation Index

Sarah N. Chiang 
1   Division of Plastic and Reconstructive Surgery, Department of Surgery, Washington University School of Medicine, St. Louis, Missouri
,
Michael J. Finnan
1   Division of Plastic and Reconstructive Surgery, Department of Surgery, Washington University School of Medicine, St. Louis, Missouri
,
Kaamya Varagur 
1   Division of Plastic and Reconstructive Surgery, Department of Surgery, Washington University School of Medicine, St. Louis, Missouri
,
Gary B. Skolnick
1   Division of Plastic and Reconstructive Surgery, Department of Surgery, Washington University School of Medicine, St. Louis, Missouri
,
Justin M. Sacks
1   Division of Plastic and Reconstructive Surgery, Department of Surgery, Washington University School of Medicine, St. Louis, Missouri
,
Joani M. Christensen
1   Division of Plastic and Reconstructive Surgery, Department of Surgery, Washington University School of Medicine, St. Louis, Missouri
› Author Affiliations
› Further Information
    Permissions and Reprints

Abstract

Background Lymphedema affects up to 34% of patients after breast cancer treatment but remains underdiagnosed and undertreated. Here, we use area deprivation index (ADI), a measure of neighborhood socioeconomic disadvantage, to determine how socioeconomic status may affect risk for and diagnosis of breast cancer-related lymphedema.

Methods Records of patients who underwent surgical treatment of breast cancer between 2017–2020 were examined. Patients' nine-digit ZIP codes were utilized to determine their deprivation level as a national ADI percentile, and those fitting into the most and least deprived quartiles were compared with evaluate lymphedema risk factors and incidence.

Results A total of 1,333 breast cancer patients were included, 812 (61%) of whom resided within the most disadvantaged ADI quartile nationally, and 521 within the least disadvantaged quartile. The most deprived group had higher rates of diabetes, obesity, and regional breast cancer, and received more extensive surgeries (7.5% modified radical mastectomy vs 1.9%, p < 0.001) and chemotherapy compared with the least disadvantaged quartile. The most disadvantaged cohort were more often at extreme risk of lymphedema utilizing the Risk Assessment Tool Evaluating Lymphedema Risk (9.1% versus 2.5%, p < 0.001); however, the incidence of lymphedema diagnoses was not significantly higher (13% vs 12%, p > 0.9). Logistic regression showed that the most deprived ADI quartile had 44% lower odds of a lymphedema diagnosis in comparison to the least deprived quartile.

Conclusion Residing in more socioeconomically disadvantaged neighborhoods is associated with lower odds of a lymphedema diagnosis, despite higher rates of risk factors for lymphedema, suggesting significant underdiagnosis in this population.

Keywords

lymphedema - social determinants of health - breast cancer - mastectomy - breast reconstruction - breast cancer-related lymphedema


Publication History

Received: 06 June 2022

Accepted: 17 September 2022

Accepted Manuscript online:
20 September 2022

Article published online:
23 October 2022

© 2022. Thieme. All rights reserved.

Thieme Medical Publishers, Inc.
333 Seventh Avenue, 18th Floor, New York, NY 10001, USA

 

  • References

  • 1 Hayes S, Di Sipio T, Rye S. et al. Prevalence and prognostic significance of secondary lymphedema following breast cancer. Lymphat Res Biol 2011; 9 (03) 135-141
    CrossrefPubMedGoogle Scholar
  • 2 Ozcinar B, Guler SA, Kocaman N, Ozkan M, Gulluoglu BM, Ozmen V. Breast cancer related lymphedema in patients with different loco-regional treatments. Breast 2012; 21 (03) 361-365
    CrossrefPubMedGoogle Scholar
  • 3 Johnson AR, Kimball S, Epstein S. et al. Lymphedema Incidence After Axillary Lymph Node Dissection: Quantifying the Impact of Radiation and the Lymphatic Microsurgical Preventive Healing Approach. Ann Plast Surg 2019; 82 (4S, Suppl 3) S234-S241
    CrossrefPubMedGoogle Scholar
  • 4 Shih YC, Xu Y, Cormier JN. et al. Incidence, treatment costs, and complications of lymphedema after breast cancer among women of working age: a 2-year follow-up study. J Clin Oncol 2009; 27 (12) 2007-2014
    CrossrefPubMedGoogle Scholar
  • 5 Taghian NR, Miller CL, Jammallo LS, O'Toole J, Skolny MN. Lymphedema following breast cancer treatment and impact on quality of life: a review. Crit Rev Oncol Hematol 2014; 92 (03) 227-234
    CrossrefPubMedGoogle Scholar
  • 6 Murphy CD, Schulick RD. Racial disparities in breast cancer: more bad news. JAMA Surg 2014; 149 (08) 796-797
    CrossrefPubMedGoogle Scholar
  • 7 Morehead-Gee AJ, Pfalzer L, Levy E. et al. Racial disparities in physical and functional domains in women with breast cancer. Support Care Cancer 2012; 20 (08) 1839-1847
    CrossrefPubMedGoogle Scholar
  • 8 Silber JH, Rosenbaum PR, Clark AS. et al. Characteristics associated with differences in survival among black and white women with breast cancer. JAMA 2013; 310 (04) 389-397
    CrossrefPubMedGoogle Scholar
  • 9 Curtis E, Quale C, Haggstrom D, Smith-Bindman R. Racial and ethnic differences in breast cancer survival: how much is explained by screening, tumor severity, biology, treatment, comorbidities, and demographics?. Cancer 2008; 112 (01) 171-180
    CrossrefPubMedGoogle Scholar
  • 10 Kwan ML, Yao S, Lee VS. et al. Race/ethnicity, genetic ancestry, and breast cancer-related lymphedema in the Pathways Study. Breast Cancer Res Treat 2016; 159 (01) 119-129
    CrossrefPubMedGoogle Scholar
  • 11 Meeske KA, Sullivan-Halley J, Smith AW. et al. Risk factors for arm lymphedema following breast cancer diagnosis in Black women and White women. Breast Cancer Res Treat 2009; 113 (02) 383-391
    CrossrefPubMedGoogle Scholar
  • 12 Black DM, Jiang J, Kuerer HM, Buchholz TA, Smith BD. Racial disparities in adoption of axillary sentinel lymph node biopsy and lymphedema risk in women with breast cancer. JAMA Surg 2014; 149 (08) 788-796
    CrossrefPubMedGoogle Scholar
  • 13 Son A, O'Donnell Jr TF, Izhakoff J, Gaebler JA, Niecko T, Iafrati MA. Lymphedema-associated comorbidities and treatment gap. J Vasc Surg Venous Lymphat Disord 2019; 7 (05) 724-730
    CrossrefPubMedGoogle Scholar
  • 14 University of Wisconsin School of Medicine and Public Health. Data from: 2019 Area Deprivation Index version 3.1. https://www.neighborhoodatlas.medicine.wisc.edu/ Jan 14, 2022
    PubMedGoogle Scholar
  • 15 Kind AJH, Buckingham WR. Making Neighborhood-Disadvantage Metrics Accessible - The Neighborhood Atlas. N Engl J Med 2018; 378 (26) 2456-2458
    CrossrefPubMedGoogle Scholar
  • 16 Rahman R, Xu AL, Dhanjani SA. et al. Does Time to Imaging and Surgery for Distal Radius Fractures Vary based on Geographic Socioeconomic Disadvantage?. Hand (N Y) 2022; 17 (1_suppl): 95S-102S
    CrossrefPubMedGoogle Scholar
  • 17 Yu KX, Yuan WJ, Huang CH. et al. Socioeconomic deprivation and survival outcomes in patients with colorectal cancer. Am J Cancer Res 2022; 12 (02) 829-838
    PubMedGoogle Scholar
  • 18 Basta MN, Wu LC, Kanchwala SK. et al. Reliable prediction of postmastectomy lymphedema: The Risk Assessment Tool Evaluating Lymphedema. Am J Surg 2017; 213 (06) 1125-1133.e1
    CrossrefPubMedGoogle Scholar
  • 19 DiSipio T, Rye S, Newman B, Hayes S. Incidence of unilateral arm lymphoedema after breast cancer: a systematic review and meta-analysis. Lancet Oncol 2013; 14 (06) 500-515
    CrossrefPubMedGoogle Scholar
  • 20 Rodriguez JR, Fuse Y, Yamamoto T. Microsurgical Strategies for Prophylaxis of Cancer-Related Extremity Lymphedema: A Comprehensive Review of the Literature. J Reconstr Microsurg 2020; 36 (07) 471-479
    Article in Thieme ConnectPubMedGoogle Scholar
  • 21 Owodunni OP, Lau BD, Florecki KL. et al. Systematic Undercoding of Diagnostic Procedures in National Inpatient Sample (NIS): A Threat to Validity Due to Surveillance Bias. Qual Manag Health Care 2021; 30 (04) 226-232
    CrossrefPubMedGoogle Scholar
  • 22 Whitburn J, Rao SR, Paul SP, Sandhu BK. Diagnosis of celiac disease is being missed in over 80% of children particularly in those from socioeconomically deprived backgrounds. Eur J Pediatr 2021; 180 (06) 1941-1946
    CrossrefPubMedGoogle Scholar
  • 23 Kroll ME, Stiller CA, Richards S, Mitchell C, Carpenter LM. Evidence for under-diagnosis of childhood acute lymphoblastic leukaemia in poorer communities within Great Britain. Br J Cancer 2012; 106 (09) 1556-1559
    CrossrefPubMedGoogle Scholar
  • 24 Lurie F, Malgor RD, Carman T. et al. The American venous forum, American vein and lymphatic society and the society for vascular medicine expert opinion consensus on lymphedema diagnosis and treatment. 37 (04) 252-266
    PubMedGoogle Scholar
  • 25 Torgbenu E, Luckett T, Buhagiar MA, Phillips JL. Guidelines relevant to diagnosis, assessment and management of lymphoedema: a systematic review. Adv Wound Care (New Rochelle) 2023; 12 (01) 15-27
    CrossrefPubMedGoogle Scholar
  • 26 Carl HM, Walia G, Bello R. et al. Systematic Review of the Surgical Treatment of Extremity Lymphedema. J Reconstr Microsurg 2017; 33 (06) 412-425
    Article in Thieme ConnectPubMedGoogle Scholar
  • 27 Curry EJ, Penvose IR, Knapp B, Parisien RL, Li X. National disparities in access to physical therapy after rotator cuff repair between patients with Medicaid vs. private health insurance. JSES Int 2021; 5 (03) 507-511
    CrossrefPubMedGoogle Scholar
  • 28 Furth SL, Hwang W, Neu AM, Fivush BA, Powe NR. Effects of patient compliance, parental education and race on nephrologists' recommendations for kidney transplantation in children. Am J Transplant 2003; 3 (01) 28-34
    CrossrefPubMedGoogle Scholar
  • 29 McLoughlin RJ, Klouda A, Hirsh MP, Cleary MA, Lightdale JR, Aidlen JT. Socioeconomic disparities in the comorbidities and surgical management of pediatric Crohn's disease. Pediatr Res 2020; 88 (06) 887-893
    CrossrefPubMedGoogle Scholar
  • 30 Brayton KM, Hirsch AT, O Brien PJ, Cheville A, Karaca-Mandic P, Rockson SG. Lymphedema prevalence and treatment benefits in cancer: impact of a therapeutic intervention on health outcomes and costs. PLoS One 2014; 9 (12) e114597 DOI: 10.1371/journal.pone.0114597.
    CrossrefPubMedGoogle Scholar
  • 31 Aldrich MB, Rasmussen JC, Fife CE, Shaitelman SF, Sevick-Muraca EM. The Development and Treatment of Lymphatic Dysfunction in Cancer Patients and Survivors. Cancers (Basel) 2020; 12 (08) E2280
    CrossrefPubMedGoogle Scholar
  • 32 Bland KL, Kosir MA. Improving the quality of life in breast cancer survivors at risk for lymphedema. Surgery 2019; 166 (04) 686-690
    CrossrefPubMedGoogle Scholar
  • 33 Kind AJ, Jencks S, Brock J. et al. Neighborhood socioeconomic disadvantage and 30-day rehospitalization: a retrospective cohort study. Ann Intern Med 2014; 161 (11) 765-774
    CrossrefPubMedGoogle Scholar
  • 34 Kim M, Kim SW, Lee SU. et al. A model to estimate the risk of breast cancer-related lymphedema: combinations of treatment-related factors of the number of dissected axillary nodes, adjuvant chemotherapy, and radiation therapy. Int J Radiat Oncol Biol Phys 2013; 86 (03) 498-503
    CrossrefPubMedGoogle Scholar
  • 35 Coen JJ, Taghian AG, Kachnic LA, Assaad SI, Powell SN. Risk of lymphedema after regional nodal irradiation with breast conservation therapy. Int J Radiat Oncol Biol Phys 2003; 55 (05) 1209-1215
    CrossrefPubMedGoogle Scholar
  • 36 Larson D, Weinstein M, Goldberg I. et al. Edema of the arm as a function of the extent of axillary surgery in patients with stage I-II carcinoma of the breast treated with primary radiotherapy. Int J Radiat Oncol Biol Phys 1986; 12 (09) 1575-1582
    CrossrefPubMedGoogle Scholar
  • 37 Darrach H, Yesantharao PS, Persing S. et al. Surgical versus Nonsurgical Management of Postmastectomy Lymphedema: A Prospective Quality of Life Investigation. J Reconstr Microsurg 2020; 36 (08) 606-615
    Article in Thieme ConnectPubMedGoogle Scholar
  • 38 Chiang SN, Skolnick GB, Westman AM, Sacks JM, Christensen JM. National Outcomes of Prophylactic Lymphovenous Bypass during Axillary Lymph Node Dissection. J Reconstr Microsurg 2022
    PubMedGoogle Scholar